Deborah Hall to Parkinson Disease
This is a "connection" page, showing publications Deborah Hall has written about Parkinson Disease.
Connection Strength
6.306
-
Racial Disparities in Parkinson Disease Clinical Phenotype, Management, and Genetics: Protocol for a Prospective Observational Study. JMIR Res Protoc. 2025 Apr 07; 14:e60587.
Score: 0.547
-
Device-aided therapies for Parkinson's disease: "All for one, one for all, that is our device". Parkinsonism Relat Disord. 2023 Nov; 116:105862.
Score: 0.491
-
An open label, non-randomized study assessing a prebiotic fiber intervention in a small cohort of Parkinson's disease participants. Nat Commun. 2023 02 18; 14(1):926.
Score: 0.471
-
Comparison of motor, non-motor, and quality of life phenotype in Black and White patients with Parkinson's disease. Parkinsonism Relat Disord. 2022 03; 96:18-21.
Score: 0.438
-
Parkinson's disease: Let food be thy medicine and medicine be thy food (Hippocrates). Parkinsonism Relat Disord. 2022 02; 95:113-114.
Score: 0.435
-
Frequency of Parkinsonism and Parkinson Disease in African Americans in the Chicago Community. J Gerontol A Biol Sci Med Sci. 2021 06 14; 76(7):1340-1345.
Score: 0.420
-
Parkinson's Disease in African Americans: A Review of the Current Literature. J Parkinsons Dis. 2020; 10(3):831-841.
Score: 0.379
-
Recruitment of patients with de novo Parkinson disease: successful strategies in a randomized exercise clinical trial. Trials. 2018 Nov 14; 19(1):630.
Score: 0.351
-
Global cognitive function and processing speed are associated with gait and balance dysfunction in Parkinson's disease. J Neuroeng Rehabil. 2016 10 28; 13(1):94.
Score: 0.304
-
FMR1 gray-zone alleles: association with Parkinson's disease in women? Mov Disord. 2011 Aug 15; 26(10):1900-6.
Score: 0.208
-
Pragmatic communication is impaired in Parkinson disease. Int J Neurosci. 2011 May; 121(5):254-6.
Score: 0.205
-
Shoulder pain in Parkinson's disease: a case-control study. Mov Disord. 2010 Jun 15; 25(8):1105-6.
Score: 0.196
-
Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease. Parkinsonism Relat Disord. 2009 Feb; 15(2):156-9.
Score: 0.171
-
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study. Lancet Neurol. 2023 11; 22(11):1015-1025.
Score: 0.122
-
Scales for Antipsychotic-Associated Movement Disorders: Systematic Review, Critique, and Recommendations. Mov Disord. 2023 06; 38(6):1008-1026.
Score: 0.119
-
Integrated Multi-Cohort Analysis of the Parkinson's Disease Gut Metagenome. Mov Disord. 2023 03; 38(3):399-409.
Score: 0.117
-
IN-HOME-PDCaregivers: The effects of a combined home visit and peer mentoring intervention for caregivers of homebound individuals with advanced Parkinson's disease. Parkinsonism Relat Disord. 2023 01; 106:105222.
Score: 0.116
-
IN-HOME-PD: The effects of longitudinal telehealth-enhanced interdisciplinary home visits on care and quality of life for homebound individuals with Parkinson's disease. Parkinsonism Relat Disord. 2022 09; 102:68-76.
Score: 0.114
-
Reply to: Cognitive Effects of Deep Brain Stimulation in GBA-Related Parkinson's Disease. Ann Neurol. 2022 08; 92(2):345-346.
Score: 0.113
-
Gut microbial metabolites in Parkinson's disease: Association with lifestyle, disease characteristics, and treatment status. Neurobiol Dis. 2022 08; 170:105780.
Score: 0.112
-
Gut-Brain Communication in Parkinson's Disease: Enteroendocrine Regulation by GLP-1. Curr Neurol Neurosci Rep. 2022 07; 22(7):335-342.
Score: 0.112
-
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers. Ann Neurol. 2022 03; 91(3):424-435.
Score: 0.109
-
Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology. 2021 11 16; 97(20):942-957.
Score: 0.108
-
KICK OUT PD: Feasibility and quality of life in the pilot karate intervention to change kinematic outcomes in Parkinson's Disease. PLoS One. 2020; 15(9):e0237777.
Score: 0.099
-
Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease: A Phase 2 Randomized Clinical Trial. JAMA Neurol. 2018 02 01; 75(2):219-226.
Score: 0.083
-
Factors Associated With Ambulatory Activity in De Novo Parkinson Disease. J Neurol Phys Ther. 2017 Apr; 41(2):93-100.
Score: 0.078
-
Study in Parkinson disease of exercise (SPARX): translating high-intensity exercise from animals to humans. Contemp Clin Trials. 2013 Sep; 36(1):90-8.
Score: 0.060
-
Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial. Phys Ther. 2012 Nov; 92(11):1395-410.
Score: 0.057
-
Profile of functional limitations and task performance among people with early- and middle-stage Parkinson disease. Phys Ther. 2011 Sep; 91(9):1339-54.
Score: 0.053
-
Endurance exercise training to improve economy of movement of people with Parkinson disease: three case reports. Phys Ther. 2008 Jan; 88(1):63-76.
Score: 0.041
-
Initial diagnoses given to persons with the fragile X associated tremor/ataxia syndrome (FXTAS). Neurology. 2005 Jul 26; 65(2):299-301.
Score: 0.035
-
RANTES-induced invasion of Th17 cells into substantia nigra potentiates dopaminergic cell loss in MPTP mouse model of Parkinson's disease. Neurobiol Dis. 2019 12; 132:104575.
Score: 0.023
-
Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders. Clin Neuropsychol. 2016 Aug; 30(6):849-900.
Score: 0.019